CO4910158A1 - Derivados de n-(imidazolilbutilo) bencenosulfonamida, su preparacion y su aplicacion en terapeutica - Google Patents
Derivados de n-(imidazolilbutilo) bencenosulfonamida, su preparacion y su aplicacion en terapeuticaInfo
- Publication number
- CO4910158A1 CO4910158A1 CO97067574A CO97067574A CO4910158A1 CO 4910158 A1 CO4910158 A1 CO 4910158A1 CO 97067574 A CO97067574 A CO 97067574A CO 97067574 A CO97067574 A CO 97067574A CO 4910158 A1 CO4910158 A1 CO 4910158A1
- Authority
- CO
- Colombia
- Prior art keywords
- group
- alkyl
- optionally substituted
- halogen atoms
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9614309A FR2756285B1 (fr) | 1996-11-22 | 1996-11-22 | Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4910158A1 true CO4910158A1 (es) | 2000-04-24 |
Family
ID=9497920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO97067574A CO4910158A1 (es) | 1996-11-22 | 1997-11-19 | Derivados de n-(imidazolilbutilo) bencenosulfonamida, su preparacion y su aplicacion en terapeutica |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0946517A1 (xx) |
| JP (1) | JP2001504128A (xx) |
| KR (1) | KR20000069063A (xx) |
| CN (1) | CN1238765A (xx) |
| AR (1) | AR009627A1 (xx) |
| AU (1) | AU5226498A (xx) |
| BG (1) | BG103414A (xx) |
| BR (1) | BR9713291A (xx) |
| CA (1) | CA2270478A1 (xx) |
| CO (1) | CO4910158A1 (xx) |
| CZ (1) | CZ178299A3 (xx) |
| EE (1) | EE9900201A (xx) |
| FR (1) | FR2756285B1 (xx) |
| HU (1) | HUP9904599A2 (xx) |
| IL (1) | IL129546A0 (xx) |
| NO (1) | NO992436L (xx) |
| SK (1) | SK66799A3 (xx) |
| TR (1) | TR199901143T2 (xx) |
| WO (1) | WO1998022443A1 (xx) |
| ZA (1) | ZA9710515B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2783521B1 (fr) * | 1998-09-18 | 2002-04-26 | Synthelabo | Derives de n-(arginyl) benzenesulfonamide, leur preparation et leur application en therapeutique |
| FR2806722B1 (fr) * | 2000-03-23 | 2002-05-17 | Sanofi Synthelabo | Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique |
| EP3201168B1 (en) | 2014-09-29 | 2020-03-18 | Cellix Bio Private Limited | Compounds and compositions for the treatment of multiple sclerosis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2689130B1 (fr) * | 1992-03-30 | 1994-05-27 | Synthelabo | Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique. |
| FR2710066B1 (fr) * | 1993-09-14 | 1995-10-20 | Synthelabo | Dérivés de 1-[2-amino-5-[1-(triphénylméthyl-1H-imidazol-4-yl]-1-oxopentyl]piperidine, leur préparation et leur utilisation comme intermédiaires de synthèse. |
| FR2727410B1 (fr) * | 1994-11-25 | 1996-12-20 | Synthelabo | Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese |
| FR2728570B1 (fr) * | 1994-12-23 | 1997-04-11 | Synthelabo | Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique |
| DE19548797A1 (de) * | 1995-12-27 | 1997-07-03 | Thomae Gmbh Dr K | Substituierte 2-Amino-imidazole, ihre Herstellung und ihre Verwendung als Arzneimittel |
-
1996
- 1996-11-22 FR FR9614309A patent/FR2756285B1/fr not_active Expired - Fee Related
-
1997
- 1997-11-19 CA CA002270478A patent/CA2270478A1/en not_active Abandoned
- 1997-11-19 BR BR9713291-8A patent/BR9713291A/pt not_active Application Discontinuation
- 1997-11-19 JP JP52328498A patent/JP2001504128A/ja active Pending
- 1997-11-19 CO CO97067574A patent/CO4910158A1/es unknown
- 1997-11-19 EE EEP199900201A patent/EE9900201A/xx unknown
- 1997-11-19 SK SK667-99A patent/SK66799A3/sk unknown
- 1997-11-19 TR TR1999/01143T patent/TR199901143T2/xx unknown
- 1997-11-19 KR KR1019997004485A patent/KR20000069063A/ko not_active Application Discontinuation
- 1997-11-19 IL IL12954697A patent/IL129546A0/xx unknown
- 1997-11-19 EP EP97947089A patent/EP0946517A1/fr not_active Ceased
- 1997-11-19 CN CN97199986A patent/CN1238765A/zh active Pending
- 1997-11-19 WO PCT/FR1997/002079 patent/WO1998022443A1/fr not_active Application Discontinuation
- 1997-11-19 HU HU9904599A patent/HUP9904599A2/hu unknown
- 1997-11-19 AU AU52264/98A patent/AU5226498A/en not_active Abandoned
- 1997-11-19 CZ CZ991782A patent/CZ178299A3/cs unknown
- 1997-11-21 AR ARP970105455A patent/AR009627A1/es unknown
- 1997-11-21 ZA ZA9710515A patent/ZA9710515B/xx unknown
-
1999
- 1999-05-19 BG BG103414A patent/BG103414A/xx unknown
- 1999-05-20 NO NO992436A patent/NO992436L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA9710515B (en) | 1998-06-10 |
| NO992436D0 (no) | 1999-05-20 |
| WO1998022443A1 (fr) | 1998-05-28 |
| HUP9904599A2 (hu) | 2000-06-28 |
| SK66799A3 (en) | 2000-02-14 |
| NO992436L (no) | 1999-07-22 |
| CZ178299A3 (cs) | 1999-08-11 |
| TR199901143T2 (xx) | 1999-08-23 |
| AU5226498A (en) | 1998-06-10 |
| FR2756285A1 (fr) | 1998-05-29 |
| JP2001504128A (ja) | 2001-03-27 |
| CA2270478A1 (en) | 1998-05-28 |
| KR20000069063A (ko) | 2000-11-25 |
| AR009627A1 (es) | 2000-04-26 |
| IL129546A0 (en) | 2000-02-29 |
| EE9900201A (et) | 1999-12-15 |
| EP0946517A1 (fr) | 1999-10-06 |
| CN1238765A (zh) | 1999-12-15 |
| BG103414A (en) | 2000-01-31 |
| FR2756285B1 (fr) | 1998-12-18 |
| BR9713291A (pt) | 1999-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR021534A1 (es) | Derivados de 1,4-diazabiciclo[3.2.2]nonano, su preparacion y su aplicacion en terapeutica | |
| AR021533A1 (es) | Derivados de 2,5-diazabiciclo[2.2.1]heptano, su preparacion y su aplicacion en terapeutica | |
| NO20052884L (no) | Substituerte indolpyridinforbindelser som anti-infeksjonsmidler. | |
| CO5640136A2 (es) | Derivados de hexahidropiridoisoquinolinas inhibidores de dpp-iv y composiciones farmaceuticas que los contienen | |
| PT1191025E (pt) | Cristais de lansoprazol | |
| ATE302775T1 (de) | Carbolinderivate | |
| DE69839735D1 (de) | Pyrimidin-5-carboxamid-derivate | |
| AR049739A1 (es) | Derivados de aril-piridina | |
| BR0208741A (pt) | Derivados de piperidina | |
| ATE346067T1 (de) | Carbolinderivate | |
| AR003414A1 (es) | Uso de derivados de imidazol [1,2-a]piridina -3-acetamida y una composicion farmaceutica que comprende tal derivado | |
| AR039988A1 (es) | Derivados de benzoxazina como moduladores de 5-ht6 y usos de los mismos | |
| NO20022232L (no) | Imidazolforbindelser for anvendelse som inhibitorer for fosfodiesterase VII | |
| DK454086D0 (da) | Quinolinderivater og deres anvendelse | |
| NO20012544L (no) | Substituerte benzo[de]isokinolin-1,3-dioner | |
| NO20043928L (no) | Komponentholder og radioisotopgenerator med en eller flere komponentholdere | |
| DE69917000D1 (de) | Butorphanol enthaltende formulierungen mit verzögerter freisetzung | |
| DE60121587D1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
| ES2043863T3 (es) | Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina. | |
| CO4910158A1 (es) | Derivados de n-(imidazolilbutilo) bencenosulfonamida, su preparacion y su aplicacion en terapeutica | |
| NO940788D0 (no) | Benzoxazin-derivater, deres fremstilling og deres terapeutiske anvendelse | |
| ES2194696T3 (es) | Compuestos quimicos. | |
| CO4940417A1 (es) | DERIVADOS DE 2,3-DIHIDROFURO[3,2-b]PIRIDINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA | |
| NO20015202D0 (no) | <beta>-hydroksyalkylamider, fremgangsmåte for deres fremstilling og deres anvendelse | |
| CO4750648A1 (es) | 5-naftalen-1-il-1,3 dioxanos, su preparacion y composiciones farmaceuticas que los contienen |